HARMONY BIOSCIENCES TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 6, 2024
Harmony Biosciences Holdings (Nasdaq: HRMY) has announced that it will release its second quarter 2024 financial results on Tuesday, August 6, 2024, before the U.S. financial markets open.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Harmony Biosciences Holdings (Nasdaq: HRMY) has announced that it will release its second quarter 2024 financial results on Tuesday, August 6, 2024, before the U.S. financial markets open. The company will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the results. Interested parties can participate in the call by dialing (800) 225-9448 (domestic) or (203) 518-9708 (international) and using the passcode HRMYQ224. It is advised to dial in at least 10 minutes before the call starts. A live and replay webcast of the call will be available on the investor page of Harmony Biosciences' website.
Details
News Market Reaction – HRMY
The recorded move for HRMY in the trading session of this news was +0.15%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
To participate in the call, please dial (800) 225-9448 (domestic) or (203) 518-9708 (international), and reference passcode HRMYQ224. It is recommended that you dial in at least 10 minutes prior to the call.
The live and replay webcast of the call will be available on the investor page of our website at https://ir.harmonybiosciences.com/.
About Harmony Biosciences
At Harmony Biosciences, we specialize in developing and delivering treatments for rare neurological diseases that others often overlook. We believe that where empathy and innovation meet, a better life can begin for people living with neurological diseases. Established by Paragon Biosciences, LLC, in 2017 and headquartered in
Harmony Biosciences Investor Contact:
Brennan Doyle
484-539-9700
bdoyle@harmonybiosciences.com
Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
cmccanless@harmonybiosciences.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-report-second-quarter-2024-financial-results-on-august-6-2024-302203230.html
SOURCE Harmony Biosciences
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.